Epstein David R
- SEC CIK
- 0001445826
In the past year, 7 open-market sale filings worth $131.6K and no purchases.
Current role at each company
- TEM Tempus AI, Inc.Directoras of Sep 3, 2026
- SGEN Seagen Inc.CEOas of Dec 15, 2023
- SNTI Senti Biosciences Holdings, Inc.Directoras of Jul 15, 2022
- EVLO Evelo Biosciences, Inc.Directoras of Jun 30, 2022
- AXLA Axcella Health Inc.Directoras of Jun 3, 2022
Show 1 more company
- RUBY Rubius Therapeutics, Inc.Directoras of May 13, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $131.6K
- 7 filings
- Net
- −$131.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Epstein David R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TEM Tempus AI, Inc.
Director15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 (view filing) | Dec 11 | 2 days | Epstein David RDirector | SSaleClass A Common Stock | −620 | $41.81 | −$25.9K | −2.2%27.9K after | 10b5-1 |
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Epstein David RDirector | SSaleClass A Common Stock | −370 | $53.31 | −$19.7K | −1.3%27.5K after | 10b5-1 |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Epstein David RDirector | SSaleClass A Common Stock | −250 | $57.52 | −$14.4K | −0.9%27.3K after | 10b5-1 |
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Epstein David RDirector | SSaleClass A Common Stock | −990 | $46.83 | −$46.4K | −3.6%26.3K after | 10b5-1 |
| May 5, 2025 (view filing) | May 1 | 4 days | Epstein David RDirector | SSaleClass A Common Stock | −370 | $53.50 | −$19.8K | −1.4%25.9K after | 10b5-1 |
| Jun 4, 2025 (view filing) | Jun 2 | 2 days | Epstein David RDirector | SSaleClass A Comnmon Stock | −250 | $55.20 | −$13.8K | −0.9%27.7K after | 10b5-1 |
| Aug 5, 2025 (view filing) | Aug 1 | 4 days | Epstein David RDirector | SSaleClass A Comnmon Stock | −370 | $55.16 | −$20.4K | −1.3%27.3K after | 10b5-1 |
| Sep 4, 2025 (view filing) | Sep 2 | 2 days | Epstein David RDirector | SSaleClass A Comnmon Stock | −250 | $73.64 | −$18.4K | −0.9%27.0K after | 10b5-1 |
| Nov 5, 2025 (view filing) | Nov 3 | 2 days | Epstein David RDirector | SSaleClass A Common Stock | −370 | $90.00 | −$33.3K | −1.4%26.7K after | 10b5-1 |
| Dec 3, 2025 (view filing) | Dec 1 | 2 days | Epstein David RDirector | SSaleClass A Comnmon Stock | −250 | $75.55 | −$18.9K | −0.9%26.4K after | 10b5-1 |
SGEN Seagen Inc.
CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 (view filing) | Nov 10 | 3 days | Epstein David RCEO | SSale | −10.6K | $213.01 | −$2.26M | −7.2%136.6K after |
EVLO Evelo Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 31, 2022 (view filing) | May 27 | 4 days | Epstein David RDirector | PPurchase | +17.1K | $1.46 | +$25.0K | +25.6%84.1K after |
RUBY Rubius Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2022 (view filing) | Apr 21 | 1 day | Epstein David RDirector | PPurchase | +30.0K | $1.44 | +$43.2K | +0.6%4.72M after |
AXLA Axcella Health Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2022 (view filing) | Mar 16 | 2 days | Epstein David RDirector | PPurchase | +26.2K | $1.91 | +$50.0K | +19.4%161.2K after |